Wednesday, June 10, 2026

pharma Β· Melanoma Β· HIV Infections

Bristol Myers Squibb

Bristol Myers Squibb clinical programs β€” 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

3401 Princeton Pike, Lawrence Township, NJ 08648, US HQ
38,146 Employees
NMPA registrant Type
Company details
Intelligence Β· Clinical Programs

Bristol Myers Squibb projects

21 ClinicalTrials.gov programs sponsored by Bristol Myers Squibb.

Bristol Myers Squibb has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. AI455-110

    Bristol-Myers Squibb

    HIV Infections

    phase 3 small molecule completed

    1 trial
  2. ATV

    Bristol-Myers Squibb

    HIV Infections

    phase 3 small molecule completed

    1 trial
  3. Daclatasvir

    Bristol-Myers Squibb

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    2 trials
  4. Deucravacitinib

    Bristol-Myers Squibb

    SjΓΆgren's Syndrome

    phase 3 small molecule active

    1 trial
  5. Enoxaparin

    Bristol-Myers Squibb

    Deep Vein Thrombosis

    phase 3 small molecule completed

    1 trial
  6. Entecavir

    Bristol-Myers Squibb

    Hepatitis B, Chronic

    phase 3 small molecule completed

    1 trial
  7. Ipilimumab

    Bristol-Myers Squibb

    Melanoma

    phase 3 small molecule completed

    1 trial
  8. KarXT

    Bristol-Myers Squibb

    Irritability Associated With Autism Spectrum Disorder

    phase 3 small molecule active

    1 trial
  9. KarXT

    Bristol-Myers Squibb

    Bipolar Disorder Type I With Mania

    phase 3 small molecule active

    1 trial
  10. Muraglitazar

    Bristol-Myers Squibb

    Diabetes, Type 2

    phase 3 small molecule completed

    1 trial
  11. NKTR-214

    Bristol-Myers Squibb

    Melanoma

    phase 3 mab completed

    1 trial
  12. Nivolumab

    Bristol-Myers Squibb

    Head and Neck Cancer

    phase 3 mab completed

    1 trial
  13. Nivolumab

    Bristol-Myers Squibb

    Brain Neoplasms

    phase 3 small molecule completed

    1 trial
  14. Nivolumab

    Bristol-Myers Squibb

    Colorectal Cancer

    phase 3 mab completed

    1 trial
  15. Nivolumab

    Bristol-Myers Squibb

    Gastric Cancer

    phase 3 small molecule completed

    1 trial
  16. Nivolumab

    Bristol-Myers Squibb

    Bladder Cancer

    phase 3 mab completed

    1 trial
  17. Repotrectinib

    Bristol-Myers Squibb

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule active

    1 trial
  18. Vinflunine

    Bristol-Myers Squibb

    Stomach Cancer

    phase 3 small molecule terminated

    1 trial
  19. muraglitazar

    Bristol-Myers Squibb

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial
  20. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 mab completed

    1 trial
  21. warfarin

    Bristol-Myers Squibb

    Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Bristol Myers Squibb have?

21 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.